Sinus Aspiration against Contrast Induced Kidney Injury: Yes or No?

Sinus Aspiration against Contrast Induced Kidney InjuryContrast induced kidney injury incidence is in direct correlation to the administered contrast. The aim of this study was to assess the safety and efficacy of sinus aspiration immediately after PCI as a measure to reduce the volume of contrast arriving in the kidneys.

 

The study included 43 patients with diabetes and renal impairment (creatinine between 1.5 and 3 mg/dL) that were candidates for a coronary angiography.

 

Sinus aspiration was performed in 18 patients out of 43, and the rest served as control group. All patients received periprocedural standard care.

 

Aspiration was done directly from a trans-septal sheath via femoral or subclavian approach in 8 patients; other 10 patients were accessed through a balloon occlusion catheter placed through the sheath simultaneously during coronary angiography.

 

The estimated contrast volume aspirated was based on the reduction in hematocrit value of the aspirate (reduced by contrast) in relation to the patient’s baseline hematocrit.  Fraction of aspirated contrast was calculated by dividing the estimated volume of aspirated contrast over the volume of injected contrast multiplied by 100.

 

Both the group receiving coronary sinus aspiration and the control group resulted similar as to clinical and lab characteristics, as well as administered contrast.

 

In the active group, aspirated contrast fraction was 39.35 ± 10.47%. Only one patient in the coronary sinus aspiration group, vs. 9 patients in the control group, presented contrast induced kidney injury (p=0.028).

 

Conclusion

Coronary sinus aspiration during coronary angiography can effectively remove up to a third of the administered contrast, reducing contrast kidney injury in selected patients.

 

Editorial Comment

This maneuver appears to be simple and logical; in fact, after reading Dr Diab’s work, most of us might have thought “how come we didn’t think of this before”.

 

This study does not report important complications, and contrast induced kidney injury reduction rate is quite significant; however, more definite conclusions call for a larger, more important study.

 

Original Title: Efficacy and Safety of Coronary Sinus Aspiration during Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.

Reference: Osama Ali Diab et al. Circ Cardiovasc Interv. 2017 Jan;10(1):e004348.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...